These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27797715)

  • 1. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
    Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
    Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
    Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
    Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
    Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
    Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
    Li H; Ruan Y; Liu C; Fan X; Yao Y; Dai Y; Song Y; Jiang D; Sun N; Jiao G; Chen Z; Fan S; Meng F; Yang H; Zhang Y; Li Z
    Cell Commun Signal; 2024 Apr; 22(1):224. PubMed ID: 38600588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.
    Liu J; Zhang N; Li Q; Zhang W; Ke F; Leng Q; Wang H; Chen J; Wang H
    PLoS One; 2011 Apr; 6(4):e19495. PubMed ID: 21559338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
    Ghadjar P; Rubie C; Aebersold DM; Keilholz U
    Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma.
    Samaniego R; Gutiérrez-González A; Gutiérrez-Seijo A; Sánchez-Gregorio S; García-Giménez J; Mercader E; Márquez-Rodas I; Avilés JA; Relloso M; Sánchez-Mateos P
    Cancer Immunol Res; 2018 Mar; 6(3):267-275. PubMed ID: 29362221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis.
    Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z
    Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.
    Geismann C; Grohmann F; Dreher A; Häsler R; Rosenstiel P; Legler K; Hauser C; Egberts JH; Sipos B; Schreiber S; Linkermann A; Hassan Z; Schneider G; Schäfer H; Arlt A
    Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):782-796. PubMed ID: 28188806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine CCL20 promotes the paclitaxel resistance of CD44
    Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CCL20-CCR6 Axis in Cancer Progression.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells.
    Liu Y; Wang J; Ni T; Wang L; Wang Y; Sun X
    Oncotarget; 2016 May; 7(18):25328-39. PubMed ID: 27015366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo.
    Sutherland A; Mirjolet JF; Maho A; Parmentier M
    Cancer Gene Ther; 2007 Oct; 14(10):847-57. PubMed ID: 17599091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.